Active ingredientRazuprotafibCat. No. P-R022-001CAS 1008510-37-9Family · Pharmaceutical analytical standards
Razuprotafib
An experimental small molecule that inhibits the phosphatase VE-PTP and thereby activates the Tie2 receptor of blood vessels: since the late 2010s it has been studied for diabetic retinopathy and then, as eye drops, for glaucoma. This family brings together the active ingredient and labelled standards.
Did you know?The Tie2 receptor helps maintain Schlemm's canal, the drainage route for the fluid inside the eye: in 2020 the eye drops, added to latanoprost, lowered eye pressure in a phase 2 study.
Go to the active ingredient →Active ingredientRazuprotafibCat. No. P-R022-001CAS 1008510-37-9
Isotopically labelledRazuprotafib-d5Cat. No. P-R022-002No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.